Clinical Trial Update: Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treosulfan-based conditioning for acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: medac GmbH | Conditions: Acute Myeloid Leukaemia | Phase 2 | Status: COMPLETED